Cognitive Deficits Completed Phase 4 Trials for Methylphenidate (DB00422)

Back to Cognitive Deficits

Also known as: Cognitive Decline / Cognitive Deficit / Cognitive Dysfunction / Impaired cognition (finding) / Cognitive impairment / Cognitive disturbance / Cognitive function abnormal

IndicationStatusPhase
DBCOND0044823 (Cognitive Deficits)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02178995Methylphenidate Treatment of Attention Deficits in EpilepsyTreatment